Hollister Inc. shifts away from wound care
By HME News Staff
Updated Mon February 5, 2018
LIBERTYVILLE, Ill. - Hollister Inc. on Feb. 2 announced its decision to divest portions of its wound care business.
Hollister, which manufactures products for not only the wound care market, but also the ostomy, continence and critical care markets, is in the process of transitioning its Hydrofera Blue and Endoform businesses to new owners, according to a press release.
The new owners, who plan to continue manufacturing and delivering the products, will be named in a “forthcoming” communication, the release says.
“For more than 95 years, our company's mission has been 'to make life more rewarding and dignified for people who use our products and services,'” said V. George Maliekel, president and CEO of Hollister. “We remain dedicated to our mission, and to serving our customers, the patients who rely on our products, and our employees around the world.”
The Hollister wound care product portfolio includes, among others, the brands Hydrofera Blue, Endoform, TRIACT and FastCast.
Hollister will continue to sell and distribute the other wound care products in its portfolio, according to the release.
A letter to customers, also dated Feb. 2, echoed much of the release, but added some color, including: “After extensive analysis and discussions, we have concluded that we will no longer pursue a path forward to build the wound care business.”
Hollister tells customers to continue ordering Hollister wound care products as they do today “until further notice.”
Comments